v3.26.1
COMBINED AND CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Class A-1 Shares
Class A-2 Shares
Total Stockholders’ Equity
Total Stockholders’ Equity
Class A-1 Shares
Total Stockholders’ Equity
Class A-2 Shares
Parent’s Net Investment
Parent’s Net Investment
Class A-1 Shares
Common Stock
Class A-1 Shares
Common Stock
Class A-2 Shares
Additional Paid-In Capital
Additional Paid-In Capital
Class A-1 Shares
Cumulative Dividends In Excess Of Earnings
Common Units of Janus OP, LLC, held by Healthpeak Properties, Inc.
Other Noncontrolling Interests
Beginning balance at Dec. 31, 2024 $ 1,308,853                            
Increase (Decrease) in Stockholders' Equity                              
Net income (loss) (4,680)                            
Net distributions to Parent (14,687)                            
Ending balance at Jun. 30, 2025 1,289,486                            
Beginning balance at Mar. 31, 2025 1,303,522                            
Increase (Decrease) in Stockholders' Equity                              
Net income (loss) (2,570)                            
Net distributions to Parent (11,466)                            
Ending balance at Jun. 30, 2025 1,289,486                            
Beginning balance at Dec. 31, 2025 1,282,310     $ 1,282,310     $ 1,282,310   $ 0 $ 0 $ 0   $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2025   0 0           0 0          
Increase (Decrease) in Stockholders' Equity                              
Net income (loss) 42,732     42,055     39,888           2,167 649 28
Net contributions from Parent 837,092     837,092     837,092                
Issuance of Class A common stock in connection with initial public offering / net of underwriting fees and offering costs   $ 821,517 $ 759   $ 821,517 $ 759   $ (2,159,290) $ 2,160 $ 759   $ 2,978,647      
Issuance of Class A common stock in connection with initial public offering / net of underwriting fees and offering costs (in shares)                 215,973,000 75,918,000          
Issuance of noncontrolling interests in connection with initial public offering 766,139                         763,402 2,737
Stock-based compensation 396     171             171       225
Common dividends (33,941)     (33,941)                 (33,941)    
Acquisition of noncontrolling interests 345                           345
Distributions to noncontrolling interests (12,530)                         (12,140) (390)
Adjustments to noncontrolling interests 0     (211,344)             (211,344)     211,344  
Ending balance at Jun. 30, 2026 3,704,819     2,738,619     0   $ 2,160 $ 759 2,767,474   (31,774) 963,255 2,945
Ending balance (in shares) at Jun. 30, 2026   215,972,996 75,917,780           215,973,000 75,918,000          
Beginning balance at Mar. 31, 2026 3,045,888     2,164,804         $ 1,872 $ 759 2,170,729   (8,556) 878,329 2,755
Beginning balance (in shares) at Mar. 31, 2026                 187,223,000 75,918,000          
Increase (Decrease) in Stockholders' Equity                              
Net income (loss) 14,858     10,723                 10,723 4,116 19
Issuance of Class A common stock in connection with initial public offering / net of underwriting fees and offering costs   $ 689,827     $ 689,827       $ 288     $ 689,539      
Issuance of Class A common stock in connection with initial public offering / net of underwriting fees and offering costs (in shares)                 28,750,000            
Stock-based compensation 363     156             156       207
Common dividends (33,941)     (33,941)                 (33,941)    
Distributions to noncontrolling interests (12,176)                         (12,140) (36)
Adjustments to noncontrolling interests 0     (92,950)             (92,950)     92,950  
Ending balance at Jun. 30, 2026 $ 3,704,819     $ 2,738,619     $ 0   $ 2,160 $ 759 $ 2,767,474   $ (31,774) $ 963,255 $ 2,945
Ending balance (in shares) at Jun. 30, 2026   215,972,996 75,917,780           215,973,000 75,918,000